Biora Therapeutics, Inc. Proceeds from Common Stock Issued
Biora Therapeutics, Inc. reported Proceeds from Common Stock Issued of $6.46 million for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2024-11-14
- Biora Therapeutics, Inc. proceeds from issuance of common stock for the quarter ending 2024-09-30 was $363.00K, a 100.55% increase year-over-year.
- Biora Therapeutics, Inc. proceeds from issuance of common stock for the quarter ending 2024-06-30 was $3.30M.
- Biora Therapeutics, Inc. proceeds from issuance of common stock for the quarter ending 2024-03-31 was $2.80M, a 78.27% decline year-over-year.
- Biora Therapeutics, Inc. proceeds from issuance of common stock for the quarter ending 2023-12-31 was $5.07M, a 98.09% increase year-over-year.
- Biora Therapeutics, Inc. proceeds from issuance of common stock for fiscal 2023 was $18.14M, a 101.21% increase from fiscal 2022.
- Biora Therapeutics, Inc. proceeds from issuance of common stock for fiscal 2022 was $9.01M, a 80.73% decline from fiscal 2021.
- Biora Therapeutics, Inc. proceeds from issuance of common stock for fiscal 2021 was $46.78M, a 59.83% decline from fiscal 2020.
- Biora Therapeutics, Inc. proceeds from issuance of common stock for fiscal 2020 was $116.44M, a 21031.58% increase from fiscal 2019.
| Period end | Proceeds from Issuance of Common Stock 1 month | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 12 month |
|---|---|---|---|---|---|
| 2024-09-30 | $363.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $3.67M derived: sum of 2 quarters · filed 2024-11-14 | $6.46M 10-Q · filed 2024-11-14 | $11.54M derived: sum of 4 quarters · filed 2024-11-14 | |
| 2024-06-30 | $3.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $6.10M 10-Q · filed 2024-08-12 | $11.18M derived: sum of 3 quarters · filed 2024-08-12 | $11.36M derived: sum of 4 quarters · filed 2024-11-14 | |
| 2024-03-31 | $2.80M 10-Q · filed 2024-05-15 | $7.87M derived: sum of 2 quarters · filed 2024-05-15 | $8.05M derived: sum of 3 quarters · filed 2024-11-14 | $8.05M derived: sum of 4 quarters · filed 2024-11-14 | |
| 2023-12-31 | $5.07M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $5.25M derived: sum of 2 quarters · filed 2024-11-14 | $5.25M derived: sum of 3 quarters · filed 2024-11-14 | $18.14M 10-K · filed 2024-04-01 | |
| 2023-09-30 | $181.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $181.00K derived: sum of 2 quarters · filed 2024-11-14 | $13.06M 10-Q · filed 2024-11-14 | $15.63M derived: sum of 4 quarters · filed 2024-11-14 | |
| 2023-06-30 | $7.30M 10-Q · filed 2024-11-14 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $12.88M 10-Q · filed 2024-08-12 | $15.44M derived: sum of 3 quarters · filed 2024-08-12 | $17.10M derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $12.88M 10-Q · filed 2024-05-15 | $15.44M derived: sum of 2 quarters · filed 2024-05-15 | $17.10M derived: sum of 3 quarters · filed 2024-05-15 | $18.27M derived: sum of 4 quarters · filed 2024-05-15 | |
| 2022-12-31 | $2.56M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $4.22M derived: sum of 2 quarters · filed 2024-04-01 | $5.39M derived: sum of 3 quarters · filed 2024-04-01 | $9.01M 10-K · filed 2024-04-01 | |
| 2022-11-30 | $9.00M 10-K · filed 2024-04-01 | ||||
| 2022-09-30 | $1.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $2.83M derived: sum of 2 quarters · filed 2023-11-13 | $6.45M 10-Q · filed 2023-11-13 | $29.82M derived: sum of 4 quarters · filed 2023-11-13 | |
| 2022-06-30 | $1.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $4.79M 10-Q · filed 2023-08-14 | $28.16M derived: sum of 3 quarters · filed 2023-08-14 | $28.19M derived: sum of 4 quarters · filed 2023-08-14 | |
| 2022-03-31 | $3.63M 10-Q · filed 2023-05-15 | $27.00M derived: sum of 2 quarters · filed 2023-05-15 | $27.02M derived: sum of 3 quarters · filed 2023-05-15 | $38.77M derived: sum of 4 quarters · filed 2023-05-15 | |
| 2021-12-31 | $23.37M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $23.40M derived: sum of 2 quarters · filed 2023-03-30 | $35.15M derived: sum of 3 quarters · filed 2023-03-30 | $46.78M 10-K · filed 2023-03-30 | |
| 2021-10-31 | $18.70M 10-K · filed 2023-03-30 | ||||
| 2021-09-30 | $30.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $11.78M derived: sum of 2 quarters · filed 2022-11-14 | $23.41M 10-Q · filed 2022-11-14 | $49.50M derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | $11.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $23.38M 10-Q · filed 2022-08-15 | $49.47M derived: sum of 3 quarters · filed 2022-08-15 | $48.88M derived: sum of 4 quarters · filed 2022-08-15 | |
| 2021-03-31 | $11.63M 10-Q · filed 2022-05-10 | $37.72M derived: sum of 2 quarters · filed 2022-05-10 | $37.13M derived: sum of 3 quarters · filed 2022-05-10 | $127.96M derived: sum of 4 quarters · filed 2022-05-10 | |
| 2020-12-31 | $26.09M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $25.50M derived: sum of 2 quarters · filed 2022-03-28 | $116.33M derived: sum of 3 quarters · filed 2022-03-28 | $116.44M 10-K · filed 2022-03-28 | |
| 2020-09-30 | -$593.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $90.24M derived: sum of 2 quarters · filed 2021-11-10 | $90.34M 10-Q · filed 2021-11-10 | $90.36M derived: sum of 4 quarters · filed 2021-11-10 | |
| 2020-08-31 | $12.20M 10-Q · filed 2021-05-13 | ||||
| 2020-06-30 | $90.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $90.94M 10-Q · filed 2021-08-12 | $90.96M derived: sum of 3 quarters · filed 2021-08-12 | $91.05M derived: sum of 4 quarters · filed 2021-08-12 | |
| 2020-03-31 | $103.00K 10-Q · filed 2021-05-13 | $124.00K derived: sum of 2 quarters · filed 2021-05-13 | $212.00K derived: sum of 3 quarters · filed 2021-05-13 | ||
| 2019-12-31 | $21.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $109.00K derived: sum of 2 quarters · filed 2021-03-18 | $551.00K 10-K · filed 2021-03-18 | ||
| 2019-09-30 | $88.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $530.00K 10-Q · filed 2020-11-09 | |||
| 2019-06-30 | $442.00K 10-Q · filed 2020-08-14 |